ANNE GRUBBS: Open Payments
NPI 1689262511 · SOUTH BOSTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 42 payments from 9 companies in 2025. Trend: 2023 $449 · 2024 $288 · 2025 $702
Food & beverage: $684Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $364 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Grifols USA, LLC | 2 | $47 |
| Electromed, Inc. | 3 | $45 |
| Verona Pharma, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Insmed, Inc. | 1 | $17 |
Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, FASENRA, Prolastin-C Liquid, SMARTVEST, BREZTRI, Ohtuvayre.
Industry payments across VA — which companies pay providers there.
